Cargando…
Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438611/ https://www.ncbi.nlm.nih.gov/pubmed/32903500 http://dx.doi.org/10.3389/fphar.2020.00992 |
_version_ | 1783572825527812096 |
---|---|
author | Akone, Sergi Herve Ntie-Kang, Fidele Stuhldreier, Fabian Ewonkem, Monique Bassomo Noah, Alexandre Mboene Mouelle, Simon Eitel Misse Müller, Rolf |
author_facet | Akone, Sergi Herve Ntie-Kang, Fidele Stuhldreier, Fabian Ewonkem, Monique Bassomo Noah, Alexandre Mboene Mouelle, Simon Eitel Misse Müller, Rolf |
author_sort | Akone, Sergi Herve |
collection | PubMed |
description | Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-coding RNAs. Emerging evidence has revealed that epigenetic dysregulations are involved in a wide range of diseases including cancers. Therefore, the reversible nature of epigenetic modifications concerning activation or inhibition of enzymes involved could be promising targets and useful tools for the elucidation of cellular and biological phenomena. In this review, emphasis is laid on natural products that inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) making them promising candidates for the development of lead structures for anticancer-drugs targeting epigenetic modifications. However, most of the natural products targeting HDAC and/or DNMT lack isoform selectivity, which is important for determining their potential use as therapeutic agents. Nevertheless, the structures presented in this review offer the well-founded basis that screening and chemical modifications of natural products will in future provide not only leads to the identification of more specific inhibitors with fewer side effects, but also important features for the elucidation of HDAC and DNMT function with respect to cancer treatment. |
format | Online Article Text |
id | pubmed-7438611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74386112020-09-03 Natural Products Impacting DNA Methyltransferases and Histone Deacetylases Akone, Sergi Herve Ntie-Kang, Fidele Stuhldreier, Fabian Ewonkem, Monique Bassomo Noah, Alexandre Mboene Mouelle, Simon Eitel Misse Müller, Rolf Front Pharmacol Pharmacology Epigenetics refers to heritable changes in gene expression and chromatin structure without change in a DNA sequence. Several epigenetic modifications and respective regulators have been reported. These include DNA methylation, chromatin remodeling, histone post-translational modifications, and non-coding RNAs. Emerging evidence has revealed that epigenetic dysregulations are involved in a wide range of diseases including cancers. Therefore, the reversible nature of epigenetic modifications concerning activation or inhibition of enzymes involved could be promising targets and useful tools for the elucidation of cellular and biological phenomena. In this review, emphasis is laid on natural products that inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) making them promising candidates for the development of lead structures for anticancer-drugs targeting epigenetic modifications. However, most of the natural products targeting HDAC and/or DNMT lack isoform selectivity, which is important for determining their potential use as therapeutic agents. Nevertheless, the structures presented in this review offer the well-founded basis that screening and chemical modifications of natural products will in future provide not only leads to the identification of more specific inhibitors with fewer side effects, but also important features for the elucidation of HDAC and DNMT function with respect to cancer treatment. Frontiers Media S.A. 2020-08-13 /pmc/articles/PMC7438611/ /pubmed/32903500 http://dx.doi.org/10.3389/fphar.2020.00992 Text en Copyright © 2020 Akone, Ntie-Kang, Stuhldreier, Ewonkem, Noah, Mouelle and Müller http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Akone, Sergi Herve Ntie-Kang, Fidele Stuhldreier, Fabian Ewonkem, Monique Bassomo Noah, Alexandre Mboene Mouelle, Simon Eitel Misse Müller, Rolf Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title_full | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title_fullStr | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title_full_unstemmed | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title_short | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases |
title_sort | natural products impacting dna methyltransferases and histone deacetylases |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438611/ https://www.ncbi.nlm.nih.gov/pubmed/32903500 http://dx.doi.org/10.3389/fphar.2020.00992 |
work_keys_str_mv | AT akonesergiherve naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT ntiekangfidele naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT stuhldreierfabian naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT ewonkemmoniquebassomo naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT noahalexandremboene naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT mouellesimoneitelmisse naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases AT mullerrolf naturalproductsimpactingdnamethyltransferasesandhistonedeacetylases |